2015Chin J Biomed EngRequires access

Effects of Dexmedetomidine infusion at different doses on anesthesia recovery period in endoscopic sinus surgery

Zhuoli Zhu, Yuping Deng

Open publisher page 0 citations

Abstract

Objective To investigate the effects of continuous Dexmedetomidine infusion given at different doses on anesthesia recovery period in endoscopic sinus surgery. Methods Between August 2014 to June 2015, 60 adult patients undergoing elective endoscopic sinus surgery under general anesthesia in our hospital were randomized to 0.2 μg·kg-1·h-1 Dexmedetomidine infusion group (group D1) , 0.5 μg·kg-1·h-1 Dexmedetomidine infusion group (group D2) and control group (group C) , with 20 patients in each group. We recorded the time of anesthesia recovery, changes in hemodynamics, SAS score and EA score changes, and incidence of adverse events in all groups. Results In Group C, the values of SBP and DBP during extubation (T1) and at 10 min after extubation (T2) were significantly higher than that before the end of surgery (T0) (both P 0.05). At extubation, patients in group D2 had lower SAS and EA scores than those in groups C and D1 (P<0.05). Patients in group D2 had less nausea, vomiting and chills compared with those in groups C and D1 (P<P <0.05). Conclusion Continuous Dexmedetomidine infusion given at 0.5 μg·kg-1 · h-1 during endoscopic sinus surgery helps maintain steady hemodynamics during anesthesia recovery period, reduce patient agitation, and does do not prolong the length of recovery period. Key words: Dexmedetomidine; Intravenous infusion; Endoscopic sinus surgery; Anesthesia recovery period

About this research paper

What this paper is about

Objective To investigate the effects of continuous Dexmedetomidine infusion given at different doses on anesthesia recovery period in endoscopic sinus surgery. Methods Between August 2014 to June 2015, 60 adult patients undergoing elective endoscopic sinus surgery under general anesthesia in our hospital were randomized to 0.2 μg·kg-1·h-1 Dexmedetomidine infusion group (group D1) , 0.5 μg·kg-1·h-1 Dexmedetomidine infusion group (group D2) and control group (group C) , with 20 patients in each group. We recorded the time of anesthesia recovery, changes in hemodynamics, SAS score and EA score changes, and incidence of adverse events in all groups. Results In Group C, the values of SBP and DBP during extubation (T1) and at 10 min after extubation (T2) were significantly higher than that before the end of surgery (T0) (both P 0.05). At extubation, patients in group D2 had lower SAS and EA scores than those in groups C and D1 (P<0.05). Patients in group D2 had less nausea, vomiting and chills compared with those in groups C and D1 (P<P <0.05). Conclusion Continuous Dexmedetomidine infusion given at 0.5 μg·kg-1 · h-1 during endoscopic sinus surgery helps maintain steady hemodynamics during anesthesia recovery period, reduce patient agitation, and does do not prolong the length of recovery period. Key words: Dexmedetomidine; Intravenous infusion; Endoscopic sinus surgery; Anesthesia recovery period

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of continuous Dexmedetomidine infusion given at different doses on anesthesia recovery period in endoscopic sinus surgery. Methods Between August 2014 to June 2015, 60 adult patients undergoing elective endoscopic sinus surgery under general anesthesia in our hospital were randomized to 0.2 μg·kg-1·h-1 Dexmedetomidine infusion group (group D1) , 0.5 μg·kg-1·h-1 Dexmedetomidine infusion group (group D2) and control group (group C) , with 20 patients in each group. We recorded the time of anesthesia recovery, changes in hemodynamics, SAS score and EA score changes, and incidence of adverse events in all groups. Results In Group C, the values of SBP and DBP during extubation (T1) and at 10 min after extubation (T2) were significantly higher than that before the end of surgery (T0) (both P 0.05). At extubation, patients in group D2 had lower SAS and EA scores than those in groups C and D1 (P<0.05). Patients in group D2 had less nausea, vomiting and chills compared with those in groups C and D1 (P<P <0.05). Conclusion Continuous Dexmedetomidine infusion given at 0.5 μg·kg-1 · h-1 during endoscopic sinus surgery helps maintain steady hemodynamics during anesthesia recovery period, reduce patient agitation, and does do not prolong the length of recovery period. Key words: Dexmedetomidine; Intravenous infusion; Endoscopic sinus surgery; Anesthesia recovery period

Key concepts: Dexmedetomidine, Medicine, Anesthesia, Chills, Nausea, Vomiting, Postoperative nausea and vomiting, Propofol

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Dexmedetomidine infusion at different doses on anesthesia recovery period in endoscopic sinus surgery — Research Paper | ScholarLens